Publications by authors named "Tom Ehlen"

Claim this Profile
Q
Qualitative Evaluation of Patient Experiences with Low-Load Blood Flow Restriction and Heavy-Load Resistance Training Post-ACL Reconstruction.
Baris Koc, Edwin Jansen, Ole de Jong, Tom Ehlen, Lisa van Rijn

Int J Sports Phys Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B Kristensen, Mahesh K B Parmar, Tom Ehlen

Lancet Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of confocal fluorescence microscopy for the detection of cervical intraepithelial neoplasia.
Fahime Sheikhzadeh, Rabab K Ward, Anita Carraro, Zhao Yang Chen, Dirk van Niekerk, Tom Ehlen

Biomed Eng Online· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.
Lori A Brotto, Yvonne Erskine, Mark Carey, Tom Ehlen, Sarah Finlayson

Gynecol Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the fallopian tube in ovarian cancer.
Alicia A Tone, Shannon Salvador, Sarah J Finlayson, Anna V Tinker, Janice S Kwon, Tom Ehlen

Clin Adv Hematol Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical technologies and molecular imaging for cervical neoplasia: a program project update.
Timon P H Buys, Scott B Cantor, Martial Guillaud, Karen Adler-Storthz, Dennis D Cox, Tom Ehlen

Gend Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Tom Ehlen, Nick S Reed

J Clin Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Ignace Vergote, Frédéric Amant, Gunnar Kristensen, Tom Ehlen, Nick S Reed

Eur J Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of surgical staging in intermediate-risk endometrial cancer.
Janice S Kwon, Mona Mazgani, Dianne M Miller, Tom Ehlen, Mark Heywood

Gynecol Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
Leen Verleye, Petronella B Ottevanger, Gunnar B Kristensen, Tom Ehlen, Nick Johnson

Eur J Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen

N Engl J Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.
Ashleen Shadeo, Raj Chari, Kim M Lonergan, Andrea Pusic, Dianne Miller, Tom Ehlen

BMC Genomics· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis